IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sofinnova Management VIII, L.L.C.

Q1 2017 Holdings

Filed 2017-04-10 | 10 holdings | $46.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)Common Stock00461U105$45.9M1,539,48099.7%
ObsEva SACommon StockH5861P103$39.0K3,749,6230.1%
Spark Therapeutics, Inc.Common Stock84652J103$37.3K699,4300.1%
Versartis, Inc.Common Stock92529L102$33.4K1,563,2600.1%
Natera, Inc.(NTRA)Common Stock632307104$13.8K1,550,2800.0%
Auris Medical Holding AGCommon SharesH03579101$7.2K7,818,1750.0%
Mirna Therapeutics, Inc.Common Stock60470J103$6.5K2,974,8120.0%
Histogenics CorporationCommon Stock43358V109$3.6K2,077,0400.0%
Innocoll Holdings PLCOrdinary SharesG4783X105$2.4K2,103,1730.0%
Sophiris Bio Inc.Common Stock83578Q209$566200,0000.0%